|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-1-12
|
|
pubmed:abstractText |
Malignant melanoma of dogs is a highly aggressive neoplasm and is the 2nd most common digit tumor. Metastatic disease is a common sequela for which few effective treatment options exist. Studies show that xenogeneic tyrosinase DNA vaccination yields immune responses and prolongation of survival in dogs with oral malignant melanoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1939-1676
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2010 by the American College of Veterinary Internal Medicine.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
94-9
|
|
pubmed:meshHeading |
pubmed-meshheading:21143299-Animals,
pubmed-meshheading:21143299-Cancer Vaccines,
pubmed-meshheading:21143299-Cohort Studies,
pubmed-meshheading:21143299-Dog Diseases,
pubmed-meshheading:21143299-Dogs,
pubmed-meshheading:21143299-Female,
pubmed-meshheading:21143299-Kaplan-Meier Estimate,
pubmed-meshheading:21143299-Male,
pubmed-meshheading:21143299-Melanoma,
pubmed-meshheading:21143299-Monophenol Monooxygenase,
pubmed-meshheading:21143299-Neoplasm Staging,
pubmed-meshheading:21143299-Proportional Hazards Models,
pubmed-meshheading:21143299-Retrospective Studies,
pubmed-meshheading:21143299-Skin Neoplasms,
pubmed-meshheading:21143299-Vaccines, DNA
|
|
pubmed:articleTitle |
Xenogeneic murine tyrosinase DNA vaccine for malignant melanoma of the digit of dogs.
|
|
pubmed:affiliation |
Donaldson-Atwood Cancer Clinic, The Animal Medical Center, New York, NY, USA. cmanley@theoncologyservice.com
|
|
pubmed:publicationType |
Journal Article
|
